Advances in Lymphoproliferative Disease: From Molecular Pathogenesis to Multitargeted Treatment

Through 5 text-based modules, 5 downloadable slidesets, and a debate discussion, CCO's expert faculty members explore current and novel agents used to treat leukemias, lymphomas, and other lymphoproliferative diseases.

CME-Certified Modules and Downloadable PowerPoint Slidesets:

Translating Science Into Clinical Practice: Recent Lessons in EGFR Inhibition, Multitargeted TKIs, and the Tumor Microenvironment

Through 4 CME-certified educational modules and accompanying downloadable slidesets, CCO's expert faculty members explore the use of targeted approaches in the treatment of cancer.

CME-Certified Modules and Downloadable PowerPoint Slidesets:

2008 Oncology Nursing Society Annual Congress

CCO's expert nursing faculty members review results presented at the 2008 Oncology Nursing meeting regarding supportive care, novel cancer therapies, and radiotherapy and surgery.

Supportive Care

Tracy K. Gosselin, RN,MSN, AOCN, and Marilyn Haas, PhD, RN, CNS, ANP-BC, review key studies presented at the 33rd Annual Congress of the Oncology Nursing Society on the supportive care of patients undergoing cancer treatment.

Novel Cancer Therapies

Pamela Hallquist Viale, RN, MS, CS, ANP, AOCNP, and Carol S. Viele, RN, MS, discuss current findings in novel therapies presented at the 2008 Oncology Nursing Society 33rd Annual Congress. Their engaging and informative talk includes topics such as new treatment options for multiple myeloma, metastatic colorectal cancer, advanced melanoma, chemotherapy-induced nausea and vomiting, chemotherapy-induced anemia, skin toxicities, and genomics.

Radiotherapy and Surgery

Carrie Daly, RN, MS, AOCN, and Annette Quinn, RN, MSN, explore key highlights from the 2008 Oncology Nursing Society meeting, including microvascular surgery of head and neck cancers, treatment options for prostate cancer, radiation therapy and other treatments for brain tumors, the palliative use of radiotherapy, and treatment options for patients with bone metastases.

CCO Slideset: 2008 Oncology Nursing Society Congress

Download slides highlighting the most important data presented at the 2008 Oncology Nursing Society Congress. Topics include updates in supportive care, novel therapies in oncology, and radiotherapy and surgical approaches. Click here to download slides.

Clinical Controversies in the Treatment of Anemia: Appropriate Use of ESAs in a Time of Change

CME-Certified Slideset Module:
Clinical Controversies in the Treatment of Anemia: Appropriate Use of ESAs in a Time of Change

Expert faculty discuss an overview of the etiology and epidemiology of anemia, the role of iron therapy in treating cancer-related anemia, and future directions for ESA therapy in these patients as determined by guidelines recommending their use and recent data from clinical trials and meta-analyses. A case-based presentation also is included to explore the appropriate use of ESAs in oncology patients.

Downloadable PowerPoint Slideset:
Clinical Controversies in the Treatment of Anemia: Appropriate Use of ESAs in a Time of Change

Download slides on the optimal treatment of oncology patients with anemia. Presentations include discussions on the etiology and epidemiology of anemia, the appropriate use of ESAs and the recent changes in guidelines recommending their use in oncology, the role of transfusion, and the future direction of ESA therapy.

Management of ER+ Postmenopausal Early Breast Cancer

CCO's expert faculty members present compelling clinical data on the use of predictive factors for guiding treatment decisions for breast cancer patients as well as therapeutic strategies and safety profiles associated with the use of tamoxifen and aromatase inhibitors.

CME-Certified Virtual Presentations:

The Role of Predictive Factors in Guiding Treatment Decisions for ER-Positive Postmenopausal Breast Cancer William J. Gradishar, MD, FACP, reviews predictive factors and prognostic assays used to stratify postmenopausal patients with early breast cancer and guide treatment decisions.

Current Hormonal Therapy Strategies for ER-Positive Postmenopausal Breast Cancer Ruth M. O’Regan, MD, reviews the clinical management of postmenopausal patients with early breast cancer receiving hormonal therapy.

Evaluating Long-Term Safety of Aromatase Inhibitors Paul E. Goss, MD, PhD, FRCPC, FRCP, reviews the long-term safety profiles of tamoxifen and aromatase inhibitors for the treatment of postmenopausal patients with early breast cancer.

Management of ER+ Postmenopausal Breast Cancer Harold J. Burstein, MD, PhD, explores treatment options for adjuvant therapy for postmenopausal women with early stage breast cancer.

CME-Certified Modules:

The Role of Predictive Factors in Guiding Treatment Decisions for Estrogen Receptor–Positive Postmenopausal Breast Cancer William Gradishar, MD, FACP, explores the use of gene signature assays and other prognostic tools to optimize treatment strategies for postmenopausal breast cancer patients.

Current Hormonal Therapy Strategies for Estrogen Receptor–Positive Postmenopausal Breast Cancer Ruth M. O’Regan, MD

Evaluating Long-Term Safety of Aromatase Inhibitors Paul E. Goss, MD, PhD, FRCPC, FRCP, reviews the safety profiles associated with the long-term use of aromatase inhibitors.

Optimizing Treatment Choices in Ovarian Cancer

Through 3 CME-certified Virtual Presentations, CCO's expert faculty members discuss current clinical management strategies for recurrent/refractory ovarian cancer, including risk factors, screening, surgery, and current and novel agents. Associated downloadable slidesets are available for use in your own presentations.

CME-Certified Virtual Presentations:

Early Detection and Treatment of Ovarian Cancer Judith K. Wolf, MD, discusses risk factors, screening strategies, and prophylactic surgery in the setting of ovarian cancer.

Current Controversies in the Management of Recurrent Ovarian Cancer Robert F. Ozols, MD, PhD, discusses current clinical management strategies for patients with recurrent ovarian cancer.

New Agents for the Management of Ovarian Cancer Bradley J. Monk, MD, discusses new agents and strategies for the clinical management of patients with ovarian cancer.

Novel Approaches in Frontline Multiple Myeloma Therapy: Understanding the Options and Implications for Transplantation

Through a CME-certified educational module and 3 Interactive Case Challenges, CCO's expert faculty members explore recent thinking regarding frontline therapy of multiple myeloma.

CME-Certified Module and Downloadable PowerPoint Slideset:

CME-Certified Interactive Case Challenges: 

• Clinical Management of a 59-Year-Old Male Patient With Multiple Myeloma and Renal Dysfunction
  Join Jean-Luc Harousseau, MD, PhD, as he discusses the clinical management of a middle-aged male patient with multiple myeloma and renal dysfunction
  
  
• Management of a Transplantation-Eligible 58-Year-Old Male With Newly Diagnosed Multiple Myeloma
  In this Interactive Case Challenge, William I. Bensinger, MD, explores therapeutic options for newly diagnosed myeloma.
  
  
• Treatment of Newly Diagnosed Multiple Myeloma in a 78-Year-Old Female
  In this Interactive Case Challenge, Kenneth Anderson, MD, reviews current clinical data and explores treatment options for an elderly patient with newly diagnosed multiple myeloma.
  

Clinical Issues and Future Directions in Hematologic Malignancies

Through 6 CME-certified Virtual Presentations, CCO’s expert faculty discuss new data presented at the 2007 Hematology meeting regarding multiple myeloma, non-Hodgkin’s lymphoma, acute leukemias, myelodysplastic syndrome, chronic myeloid leukemia, and chronic lymphocytic leukemia. The accompanying downloadable slidesets can be used for further study or in your own presentations.

CME-Certified Virtual Presentations and Downloadable PowerPoint Slidesets:

• Multiple Myeloma
  Amitabha Mazumder, MD, discusses new data in multiple myeloma presented at the 2007 hematology meeting.
  
  
• Non-Hodgkin’s Lymphoma
  Sandra J. Horning, MD, discusses results presented at the 2007 hematology meeting regarding current and novel therapeutic approaches for treating patients with non-Hodgkin’s lymphoma.
  
  
• Acute Leukemias
  Farhad Ravandi, MD, discusses results presented at the 2007 hematology meeting regarding acute leukemias.
  
  
• Myelodysplastic Syndrome    
  Allen S. Yang, MD, PhD, discusses results presented at the 2007 hematology meeting regarding current and novel therapeutic approaches for treating patients with myelodysplastic syndrome.
  
  
• Chronic Myeloid Leukemia      
  Neil Shah, MD, PhD, discusses results presented at the 2007 hematology meeting regarding current and novel therapeutic approaches for treating patients with chronic myeloid leukemia.
  
  
• Chronic Lymphocytic Leukemia      
  Michael J. Keating, MB BS, discusses results presented at the 2007 hematology meeting regarding chronic lymphocytic leukemia.

2008 American Society of Clinical Oncology Annual Meeting

CCO's independent coverage of the 2008 Clinical Oncology meeting includes Capsule Summaries of key presentations, as well as Expert Analyses, Expert Recaps, and brief video Expert Highlights that focus on key issues highlighted at the conference.

• Breast Cancer
  William J. Gradishar, MD; FACP Clifford A. Hudis, MD; and Kathy D. Miller, MD
  
  
• Gastrointestinal Cancers
  Axel Grothey, MD; John L. Marshall, MD; and Richard M. Goldberg, MD
  
  
• Genitourinary Cancers
  Brian I. Rini, MD; David I. Quinn, MD, PhD; and Nicholas J. Vogelzang, MD
  
  
• Hematologic Malignancies
  Andre Goy, MD, MPH; Hagop M. Kantarjian, MD; and Sagar Lonial, MD
  
  
• Lung Cancer
  David R. Gandara, MD; Thomas J. Lynch, MD; and Alan B. Sandler, MD
  
  
• Ovarian Cancer
  Coming Soon!

Download short video and audio reviews of key treatment areas by Ramaswamy Govindan, MD; Kathy D. Miller, MD; Richard M. Goldberg, MD; Brian I. Rini, MD; and Hagop Kantarjian, MD.

Attacking the Signal at the Switch: Unraveling the Mysteries of mTOR Inhibition in Multiple Tumor Types

Through 5 CME-certified educational modules, CCO's expert faculty members explore the rationale for mTOR inhibition as an approach to cancer therapy, review the latest trial results in renal cell carcinoma and other solid tumors and hematologic cancers, and discuss how mTOR inhibitors may be integrated into current treatment regimens.

Now Available!

CME-Certified Modules:

Master Class in Management of Liver Metastases From Colorectal Cancer: Case-Based Learning

Now Available!

Virtual Presentation:

CCO Slideset:

Treatment Challenges in Myelodysplastic Syndromes

Through a CME-certified educational module and Interactive Case Challenges, CCO's expert faculty members review the latest data on the treatment of myelodysplastic syndromes and explore realistic clinical situations.

CME-certified Module:

• Insights Into the Pathogenesis, Classification, and Treatment of Myelodysplastic Syndromes
  Alan F. List, MD, reviews current clinical trial data regarding the clinical management of patients with MDS.
  

CME-certified Case Challenges:

• Clinical Management of a 69-Year-Old Man With Intermediate-1-Risk Myelodysplastic Syndrome
  In this Interactive Case Challenge, Azra Raza, MD, and Naomi Galili, PhD, discuss treatment options for a patient with intermediate-risk myelodysplastic syndrome and monosomy of chromosome 7.
  
• Management of a 69-Year-Old Patient With Deletion 5q Myelodysplastic Syndrome
  Alan F. List, MD, reviews treatment options for a patient with del(5q) MDS.
  
• Treatment of a 52-Year-Old Man With High-Risk Myelodysplastic Syndrome
  Charles A. Schiffer, MD, presents treatment options for a patient with newly diagnosed high-risk myelodysplastic syndrome.

2008 Genitourinary Cancers Symposium

Nicholas J. Vogelzang, MD, and David I. Quinn, MD, discuss the most important clinical data presented at the 2008 Genitourinary Cancers Symposium, including recent findings on prevention, screening, diagnosis, treatment approaches, and current controversies in the management of cancers of the prostate, kidney, bladder, and testes.

CME-Certified Module:

• Conference Report: Prostate, Renal Cell, and Bladder Cancer
  David I. Quinn, MD, PhD and Nicholas J. Vogelzang, MD

Practical Answers to Key Clinical Challenges: Optimizing Patient Outcomes in Breast Cancer

In this CME-certified educational module based on the results of a readership survey, Kathy S. Albain, MD; Kathy D. Miller, MD; Hope S. Rugo, MD; and Linda T. Vahdat, MD, discuss breast cancer cases and optimal treatment regimens for patients in the adjuvant, neoadjuvant, and metastatic settings. A downloadable slideset accompanies the module.

Click here to begin.

2008 Gastrointestinal Cancers Symposium

CCO's independent coverage of the 2008 Gastrointestinal Cancers Symposium includes 3 CME-certified Conference Reports and an accompanying downloadable slideset focusing on key presentations at the conference.

• Melanoma Treatment Update
  Through 4 CME-certified educational modules, CCO’s expert faculty members review the latest data on the treatment of melanoma.
  
  
• Advances in Metastatic Colorectal Cancer: Molecular Pathways, Biomarkers, and Clinical Results
  This series of CME-certified Expert Recaps and accompanying downloadable slidesets provides a comprehensive update on the use of targeted treatments and biomarkers to optimize patient outcomes in metastatic colorectal cancer. Developed with Clinical Care Options' expert faculty members, these slidesets are available for use as a self-study resource or in your own presentations.
  
  
• 6th International Symposium on Translational Research in Oncology
  Through 8 CME-certified slidesets, CCO's expert faculty members, including Program Directors Dennis J. Slamon, MD, PhD, and John Crown, MD, MPH, review the latest data based on translational research in oncology that were presented at the International Translational Research in Oncology meeting held in Dublin, Ireland, in October 2007.
  
  
• Tumor Immunology: Treatment Approaches With Immunotherapies in Human Cancer
  Review 3 CME-certified modules and a downloadable slideset.
  
  
• Advances in the Treatment of Lymphoproliferative Malignancies: Promising Directions in Mantle Cell Lymphoma, Follicular Lymphoma, and Waldenstrom’s Macroglobulinemia
  Access 4 interactive modules and downloadable slidesets.
  
  
• Anthracyclines in the Treatment of Multiple Myeloma: Traditional and Evolving Roles
  Through a CME-certified educational module, CCO's expert faculty review the use of anthracyclines in the treatment of patients with multiple myeloma and help you to apply this information in real-world scenarios through CME-certified interactive case challenges.
  
  
• Imatinib Resistance in the Treatment of Chronic Myeloid Leukemia: Current Management Options and Emerging Therapies
  In this CME-certified educational module, Elias Jabbour, MD; Jorge E. Cortes, MD; and Hagop M. Kantarjian, MD, discuss current and evolving treatments for chronic myeloid leukemia.
  
  
• Navigating Multiple Pathways: Evolving Options and Future Directions in Targeted Therapies
  In this series of 3 educational modules with accompanying downloadable slidesets, CCO's expert oncology faculty members discuss the use of targeted agents as well as the utility of the tumor microenvironment as a therapeutic target.

• 2008 Oncology Nursing Society Annual Congress*
  
  
• 2008 American Society of Clinical Oncology Annual Meeting *
  
  
• 2008 Genitourinary Cancers Symposium*
  
  
• 2008 Gastrointestinal Cancers Symposium*
  
  
• 2007 American Society of Hematology Annual Meeting*
  
  
• 2007 San Antonio Breast Cancer Symposium*
  
  
  

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Adjuvant HER2-Positive Cancer: Integrating Prognostic Tools and Clinical Advances to Optimize Treatment

• Current Clinical Data on Adjuvant Therapy for HER2-Positive Breast Cancer
• Estimating Benefit and Prognosis With Adjuvant Therapy for HER2-Positive Breast Cancer
• Treatment of a 32-Year-Old Patient With HER2-Positive Breast Cancer
• Treatment of Breast Cancer in a 64-Year-Old Black Female With Multiple Positive Lymph Nodes
• Assessing Breast Cancer Prognosis and Applications for Clinical Practice

Research Priorities in Colorectal Cancer: Recommendations of the Scientific Leadership Council in GI Cancer of the Coalition of Cancer Cooperative Groups Colorectal Cancer: Demographics and Screening

• Colorectal Cancer Prevention
• Colorectal Cancer Detection and Diagnosis
• Adjuvant Treatment for Rectal Cancer
• Adjuvant Treatment for Colon Cancer
• Advanced Colorectal Cancer and Novel Therapies

Breast Cancer

• Treatment of a 32-Year-Old Patient With HER2-Positive Breast Cancer
• Treatment of Breast Cancer in a 64-Year-Old Black Female With Multiple Positive Lymph Nodes
  
  

Multiple Myeloma

• Anthracycline Therapy in a 55-Year-Old Man With Relapsed Multiple Myeloma
• Anthracycline Therapy in a 67-Year-Old Man With Multiple Myeloma Who Has Relapsed After ASCT
  

Topics

• Breast Cancer
• Gastrointestinal Cancer
• General Hematology
• Genitourinary Cancer
• Gynecologic Cancer
• Head and Neck Cancer
• Hematologic Malignancies
• Lung Cancer

Resources

• Advanced Search
• Case Challenges
• Live Events
• Slide Download Library
• Free Bookstore

FEATURED VIDEO SEGMENT
Expert Highlight: Lung Cancer

Ramaswamy Govindan, MD, examines the results of the phase III FLEX trial of cetuximab added to cisplatin/vinorelbine chemotherapy in advanced non-small-cell lung cancer along with other key clinical trial data presented in Chicago. Click here to start.

NSABP C-07 Update: Trend Points to Improved 5-Year Survival With Adjuvant Oxaliplatin Added to 5-FU/LV in Colon Cancer

Latest data from large phase III trial in patients with stage II/III colon cancer suggest improved OS at 5 years-and confirm superior PFS-for oxaliplatin added to 5-FU/LV in adjuvant therapy

Click here for related Capsule Summaries.

Click here for the more slides.

Click here to visit the bookstore.

Click here for more cases.